This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Monitoring of Tissue Transfer Flaps by Modulated Imaging

This study is currently recruiting participants.
See Contacts and Locations
Verified February 2017 by Beckman Laser Institute and Medical Center, University of California, Irvine
Sponsor:
Collaborator:
Beckman Laser Institute University of California Irvine
Information provided by (Responsible Party):
Beckman Laser Institute and Medical Center, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT00792792
First received: November 14, 2008
Last updated: February 8, 2017
Last verified: February 2017
  Purpose
Tissue transfer flaps are a method of moving tissue from a donor location to a recipient location. In the case of a free tissue transfer flaps, the blood vessels to the transferred tissues are detached and then re-attached to different arteries and veins at the recipient site. The process of reconstructive surgery using tissue transfer flaps is not without complications. These complications may include acute arterial or venous occlusion, as well as the development of late complications such as fat necrosis and flap atrophy.

Condition Intervention
Other Reconstructive Surgery Device: Modulated Imaging

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Non-contact, Intra-operative & Post-operative Device, Evaluation of Tissue Transfer Flaps After Reconstructive Surgery.

Resource links provided by NLM:


Further study details as provided by Beckman Laser Institute and Medical Center, University of California, Irvine:

Primary Outcome Measures:
  • Transfer Skin flap [ Time Frame: up to 6 weeks ]

Estimated Enrollment: 200
Study Start Date: January 2007
Estimated Study Completion Date: June 2018
Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Tissue transfer skin flap
Modulated Imaging Spectroscopy
Device: Modulated Imaging
Modulated Imaging Spectroscopy

Detailed Description:
The researchers developed a safe, non-contact, intra-operative and post-operative device called Modulated Imaging, can detect changes in a flap's optical properties and can correlate with arterial or venous occlusion or with the development of fat necrosis or flap atrophy.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Study population will be selected from Surgical Department as outpatients and in-patient bases that require reconstructive surgery using a pedicle or free tissue transfer flap.
Criteria

Inclusion Criteria:

  • Adult 18 years and older planned to undergo reconstructive surgery

Exclusion Criteria:

  • All emergency reconstructive surgery
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00792792

Contacts
Contact: Ata Sharif, MD 714-456-5755 sharifs@uci.edu
Contact: Christopher Ellstrom, MD 714-456-5755 ellstros@uci.edu

Locations
United States, California
University of California Medical Center Recruiting
Orange, California, United States, 92868
Contact: Ata Sharif, MD    714-456-5755    sharifs@uci.edu   
Contact: Christopher Ellstrom, MD    714.456.5755    ellstros@uci.edu   
Principal Investigator: Gregory R Evans, MD         
Sub-Investigator: Mark R Kobayashi, M.D         
Sub-Investigator: Garrett A Wirth, M.D.         
Sub-Investigator: Anthony J Durkin, Ph.D.         
Sub-Investigator: Thomas Scholz, M.D         
Sub-Investigator: Aaron Kosins, M.D         
Sub-Investigator: Rolf B Saager, PhD         
Sub-Investigator: Keyianoosh Z Paydar, MD         
Sub-Investigator: Ata Sharif, MD         
Sub-Investigator: Adrien Ponticorvo, PhD         
Sub-Investigator: Christopher Ellstrom, MD         
Sponsors and Collaborators
University of California, Irvine
Beckman Laser Institute University of California Irvine
Investigators
Principal Investigator: Evans R Gregory, PhD Aesthetic & Plastic Surgery Institute, UCIMC
  More Information

Responsible Party: Beckman Laser Institute and Medical Center, Gregory Evans, M.D., Chair, Department of Plastic Surgery, University of California, Irvine
ClinicalTrials.gov Identifier: NCT00792792     History of Changes
Other Study ID Numbers: NIH/LAMMP-2007-5891
Study First Received: November 14, 2008
Last Updated: February 8, 2017

Keywords provided by Beckman Laser Institute and Medical Center, University of California, Irvine:
tissue transfer

ClinicalTrials.gov processed this record on September 21, 2017